Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.

Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.

About 30% stage I non-small cell lung cancer (NSCLC) patients undergoing resection will recur. Robust prognostic markers are required to better manage therapy options. The purpose of this study is to develop and validate a novel gene-expression signature that can predict tumor recurrence of stage I...

Full description

Bibliographic Details
Main Authors: Yan Lu, Liang Wang, Pengyuan Liu, Ping Yang, Ming You
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3264655?pdf=render

Internet

http://europepmc.org/articles/PMC3264655?pdf=render

Similar Items